Cargando…

The background occurrence of selected clinical conditions prior to the start of an extensive national vaccination program in Japan

INTRODUCTION: The COVID-19 pandemic caused by SARS-CoV-2 has now affected tens of millions of people globally. It is the hope that vaccines against SARS-CoV-2 will deliver a comprehensive solution to this global pandemic; however, this will require extensive national vaccination programs. Ultimately...

Descripción completa

Detalles Bibliográficos
Autores principales: Sobue, Tomotaka, Fukuda, Haruhisa, Matsumoto, Tetsuya, Lee, Bennett, Ito, Shuhei, Iwata, Satoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8389412/
https://www.ncbi.nlm.nih.gov/pubmed/34437567
http://dx.doi.org/10.1371/journal.pone.0256379
_version_ 1783742854440419328
author Sobue, Tomotaka
Fukuda, Haruhisa
Matsumoto, Tetsuya
Lee, Bennett
Ito, Shuhei
Iwata, Satoshi
author_facet Sobue, Tomotaka
Fukuda, Haruhisa
Matsumoto, Tetsuya
Lee, Bennett
Ito, Shuhei
Iwata, Satoshi
author_sort Sobue, Tomotaka
collection PubMed
description INTRODUCTION: The COVID-19 pandemic caused by SARS-CoV-2 has now affected tens of millions of people globally. It is the hope that vaccines against SARS-CoV-2 will deliver a comprehensive solution to this global pandemic; however, this will require extensive national vaccination programs. Ultimately, clinical conditions and even sudden unexplained death will occur around the time of vaccination, thus a distinction needs to be made between events that are causally related to the vaccine or temporally related to vaccination. This study aimed to estimate the background occurrence of 43 clinical conditions in the Japanese population. METHODS: A retrospective cohort study was conducted from 2013 to 2019 using data from two large healthcare claims databases (MDV and JMDC) in Japan. The estimated number of new cases and incidence were calculated based on the actual number of new cases identified in the databases. The PubMed and Ichushi-web databases, as well as grey literature such as guidelines and government statistics, were also searched to identify any publications related to incidence of these conditions in Japan. RESULTS AND CONCLUSION: The estimates of the number of total cases and incidence were similar for the MDV and JMDC databases for some diseases. In addition, some estimates were similar to those in the scientific literature. For example, from the MDV and JMDC databases, estimates of incidence of confirmed Bell’s palsy in 2019 were 41.7 and 47.9 cases per 100,000 population per year, respectively. These estimates were of the same order from the scientific publication. Determining whether clinical conditions occurring around the time of vaccination are causally or only temporally related to vaccination will be critical for public health decision makers as well as for the general public. Comparison of background occurrence at the population level may provide some additional objective evidence for the evaluation of temporality or causality.
format Online
Article
Text
id pubmed-8389412
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-83894122021-08-27 The background occurrence of selected clinical conditions prior to the start of an extensive national vaccination program in Japan Sobue, Tomotaka Fukuda, Haruhisa Matsumoto, Tetsuya Lee, Bennett Ito, Shuhei Iwata, Satoshi PLoS One Research Article INTRODUCTION: The COVID-19 pandemic caused by SARS-CoV-2 has now affected tens of millions of people globally. It is the hope that vaccines against SARS-CoV-2 will deliver a comprehensive solution to this global pandemic; however, this will require extensive national vaccination programs. Ultimately, clinical conditions and even sudden unexplained death will occur around the time of vaccination, thus a distinction needs to be made between events that are causally related to the vaccine or temporally related to vaccination. This study aimed to estimate the background occurrence of 43 clinical conditions in the Japanese population. METHODS: A retrospective cohort study was conducted from 2013 to 2019 using data from two large healthcare claims databases (MDV and JMDC) in Japan. The estimated number of new cases and incidence were calculated based on the actual number of new cases identified in the databases. The PubMed and Ichushi-web databases, as well as grey literature such as guidelines and government statistics, were also searched to identify any publications related to incidence of these conditions in Japan. RESULTS AND CONCLUSION: The estimates of the number of total cases and incidence were similar for the MDV and JMDC databases for some diseases. In addition, some estimates were similar to those in the scientific literature. For example, from the MDV and JMDC databases, estimates of incidence of confirmed Bell’s palsy in 2019 were 41.7 and 47.9 cases per 100,000 population per year, respectively. These estimates were of the same order from the scientific publication. Determining whether clinical conditions occurring around the time of vaccination are causally or only temporally related to vaccination will be critical for public health decision makers as well as for the general public. Comparison of background occurrence at the population level may provide some additional objective evidence for the evaluation of temporality or causality. Public Library of Science 2021-08-26 /pmc/articles/PMC8389412/ /pubmed/34437567 http://dx.doi.org/10.1371/journal.pone.0256379 Text en © 2021 Sobue et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Sobue, Tomotaka
Fukuda, Haruhisa
Matsumoto, Tetsuya
Lee, Bennett
Ito, Shuhei
Iwata, Satoshi
The background occurrence of selected clinical conditions prior to the start of an extensive national vaccination program in Japan
title The background occurrence of selected clinical conditions prior to the start of an extensive national vaccination program in Japan
title_full The background occurrence of selected clinical conditions prior to the start of an extensive national vaccination program in Japan
title_fullStr The background occurrence of selected clinical conditions prior to the start of an extensive national vaccination program in Japan
title_full_unstemmed The background occurrence of selected clinical conditions prior to the start of an extensive national vaccination program in Japan
title_short The background occurrence of selected clinical conditions prior to the start of an extensive national vaccination program in Japan
title_sort background occurrence of selected clinical conditions prior to the start of an extensive national vaccination program in japan
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8389412/
https://www.ncbi.nlm.nih.gov/pubmed/34437567
http://dx.doi.org/10.1371/journal.pone.0256379
work_keys_str_mv AT sobuetomotaka thebackgroundoccurrenceofselectedclinicalconditionspriortothestartofanextensivenationalvaccinationprograminjapan
AT fukudaharuhisa thebackgroundoccurrenceofselectedclinicalconditionspriortothestartofanextensivenationalvaccinationprograminjapan
AT matsumototetsuya thebackgroundoccurrenceofselectedclinicalconditionspriortothestartofanextensivenationalvaccinationprograminjapan
AT leebennett thebackgroundoccurrenceofselectedclinicalconditionspriortothestartofanextensivenationalvaccinationprograminjapan
AT itoshuhei thebackgroundoccurrenceofselectedclinicalconditionspriortothestartofanextensivenationalvaccinationprograminjapan
AT iwatasatoshi thebackgroundoccurrenceofselectedclinicalconditionspriortothestartofanextensivenationalvaccinationprograminjapan
AT sobuetomotaka backgroundoccurrenceofselectedclinicalconditionspriortothestartofanextensivenationalvaccinationprograminjapan
AT fukudaharuhisa backgroundoccurrenceofselectedclinicalconditionspriortothestartofanextensivenationalvaccinationprograminjapan
AT matsumototetsuya backgroundoccurrenceofselectedclinicalconditionspriortothestartofanextensivenationalvaccinationprograminjapan
AT leebennett backgroundoccurrenceofselectedclinicalconditionspriortothestartofanextensivenationalvaccinationprograminjapan
AT itoshuhei backgroundoccurrenceofselectedclinicalconditionspriortothestartofanextensivenationalvaccinationprograminjapan
AT iwatasatoshi backgroundoccurrenceofselectedclinicalconditionspriortothestartofanextensivenationalvaccinationprograminjapan